To explore the existing practice models and practice opportunities surrounding pharmacist-delivered Medicare Annual Wellness Visits (AWVs), with the goal of improving patient access through advanced pharmacy-based health services.
Data Sources:
English-language articles published in peer-reviewed journals from January 2011 to March 2018 were reviewed by searching PubMed and Google Scholar databases using permutations of terms such as “pharmacist/pharmacy,” “Medicare,” “Annual Wellness Visit,” “develop/development,” and “implement/implementation.”
Study Selection and Data Extraction:
Original articles reporting resources (inputs), processes, and programmatic outcomes (uptake and delivery, interventions made, financial models, satisfaction) of pharmacist-delivered AWV services were retained.
Data Synthesis:
Eight articles describing 6 unique studies representing current pharmacist-delivered AWV practices were included in the final review. All identified articles used observational study designs and were published in peer-reviewed journals from 2014 to 2017. Five studies utilized staff (in-house) pharmacists working in internal or family medicine clinics via collaborative practice agreements; one study described a model for outsourcing AWV services through a community pharmacy. Pharmacists completed 37 to 300 AWVs and performed both medication- and non-medication-related interventions, with a mean of 3.5 to 5.4 interventions/patient. Quarterly revenue ranged from $3750 to $22 340 (USD), with 40 pharmacist-hours required for initial program development.
Implications for Patient Care and Clinical Practice:
This scoping review will serve as a guide for pharmacists wishing to implement AWV services in their own practices.
Conclusions:
There is opportunity for ambulatory/community pharmacists to expand their practices to include AWV services in states that allow collaborative practice agreements. Interprofessional collaboration between physicians and pharmacists can optimize and aid adoption of pharmacist-delivered AWV services.
AndersonGHorvathJ. The growing burden of chronic disease in America. Public Health Rep. 2004;119(3):263–270.
7.
WardJEGordonJSanson-FisherRW. Strategies to increase preventive care in general practice. Med J Aust. 1991;154(8):523–531.
8.
TrivediANRakowskiWAyanianJZ. Effect of cost sharing on screening mammography in Medicare health plans. N Engl J Med. 2008;358(4):375–383.
9.
SolankiGSchaufflerHHMillerLS. The direct and indirect effects of cost-sharing on the use of preventive services. Health Serv Res. 2000;34(6):1331–1350.
10.
SolankiGSchaufflerHH. Cost-sharing and the utilization of clinical preventive services. Am J Prev Med. 1999;17(2):127–133.
11.
KohHKSebeliusKG. Promoting prevention through the Affordable Care Act. N Engl J Med. 2010;363(14):1296–1299.
BluesteinDDiduk-SmithRJordanLPersaudKHughesT. Medicare annual wellness visits: how to get patients and physicians on board. Fam Pract Manag. 2017;24(2):12–16.
16.
HughesC.Medicare annual wellness visits: don’t forget the health risk assessment. Fam Pract Manag. 2012;19(2):11–14.
HuJJensenGANerenzD, et al.Medicare’s annual wellness visit in a large health care organization: who is using it?Ann Intern Med. 2015;163(7):567–568.
19.
GalvinSLGrandyRWoodallT, et al.Improved utilization of preventive services among patients following team-based annual wellness visits. N. C. Med J. 2017;78(5):287–295.
SambamoorthiUMcAlpineDD. Racial, ethnic, socioeconomic, and access disparities in the use of preventive services among women. Prev Med. 2003;37(5):475–484.
22.
BenjaminsMRKirbyJBHuieSAB. County characteristics and racial and ethnic disparities in the use of preventive services. Prev Med. 2004;39(4):704–712.
23.
ChenJYDiamantAPouratN, et al.Racial/ethnic disparities in the use of preventive services among the elderly. Am J Prev Med. 2005;29(5):388–395.
24.
YlitaloKRLeeHMehtaNK. Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US national immunization survey. Am J Public Health. 2013;103(1):164–169.
25.
WaltzTJPowellBJMatthieuMM, et al.Use of concept mapping to characterize relationships among implementation strategies and assess their feasibility and importance: results from the Expert Recommendations for Implementing Change (ERIC) study. Implement Sci. 2015;10(1):109.
26.
GarwoodCLKorkisBMohammadI, et al.Implementation of chronic care management services in primary care practice. Am J Health Syst Pharm. 2016;73(23):1924–1932.
27.
BeliardRCMerreyJW. Evaluation of interventions in clinical pharmacist-led annual Medicare wellness visits compared with usual care. Consult Pharm. 2017;32(11):687–699.
28.
WilsonCGParkISutherlandSE, et al.Assessing pharmacist-led annual wellness visits: interventions made and patient and physician satisfaction. J Am Pharm Assoc (2003). 2015;55(4):449–454.
29.
ThomasMH. Development and implementation of a pharmacist-delivered Medicare annual wellness visit at a family practice office. J Am Pharm Assoc (2003). 2014;54(4):427–434.
30.
GrantMJBoothA. A typology of reviews: an analysis of 14 review types and associated methodologies. Health Info Libr J. 2009;26(2):91–108.
31.
AlhossanAKennedyALealS. Outcomes of annual wellness visits provided by pharmacists in an accountable care organization associated with a federally qualified health center. Am J Health Syst Pharm. 2016;73(4):225–228.
32.
EvansTAFabelPHZieglerB. Community pharmacist–delivered Medicare annual wellness visits within a family medicine practice. J Am Pharm Assoc (2003). 2017;57(3):S247–S251.
33.
WarshanyKSherrillCHCavanaughJ, et al.Medicare annual wellness visits conducted by a pharmacist in an internal medicine clinic. Am J Health Syst Pharm. 2014;71(1):44–49.
34.
SherrillCHCavanaughJShillidayBB. Patient satisfaction with Medicare annual wellness visits administered by a clinical pharmacist practitioner. J Manag Care Spec Pharm. 2017;23(11):1125–1129.
35.
ParkISutherlandSERayL, et al.Financial implications of pharmacist-led Medicare annual wellness visits. J Am Pharm Assoc (2003). 2014;54(4):435–440.
36.
GanguliISouzaJMcWilliamsJM, et al.Trends in use of the US Medicare annual wellness visit, 2011-2014. JAMA. 2017;317(21):2233–2235.
37.
GoetzelRStaleyPOgdenL, et al.A framework for patient-centered health risk assessments—providing health promotion and disease prevention services to Medicare beneficiaries. Published 2011. Accessed March 22, 2018. https://www.cdc.gov/policy/hst/hra/frameworkforhra.pdf
38.
MilesRESnowCC. Designing strategic human resources systems. Organ Dyn. 1984;13(1):36–52.
39.
MorenoGLonowskiSFuJ, et al.Physician experiences with clinical pharmacists in primary care teams. J Am Pharm Assoc (2003). 2017;57(6):686–691.
40.
WilliamsCRWoodallTWilsonCG, et al.Physician perceptions of integrating advanced practice pharmacists into practice. J Am Pharm Assoc (2003). 2018;58(1):73–78.e72.
41.
WestrickSC. Forward and backward transitions in pharmacy-based immunization services. Res Social Adm Pharm. 2010;6(1):18–31.
42.
YoshizukaKKnappKKShanePA, et al.Inserting pharmacists in primary care roles in an ambulatory care setting. California J Health Syst Pharm. 2015;27(1):15–28.
43.
BenjaminM; American Pharmacists Association Foundation, American Pharmacists Association. Consortium recommendations for advancing pharmacists’ patient care services and collaborative practice agreements. J Am Pharm Assoc. 2013;53(2):e132–e141.
44.
Centers for Disease Control & Prevention. Advancing team-based care through collaborative practice agreements: a resource and implementation guide for adding pharmacists to the care team. Published 2017. Accessed February 8, 2017. https://www.cdc.gov/dhdsp/pubs/docs/CPA-Team-Based-Care.pdf
